Results 301 to 310 of about 326,396 (335)

Genome-wide association study of post COVID-19 syndrome in a population-based cohort in Germany. [PDF]

Sci Rep
Ruß AK, Schreiber S, Lieb W, Vehreschild JJ, Heuschmann PU, Illig T, Appel KS, Vehreschild MJGT, Krefting D, Reinke L, Viebke A, Poick S, Störk S, Reese JP, Zoller T, Krist L, Ellinghaus D, Foesel BU, Gieger C, Lorenz-Depiereux B, Witzenrath M, Anton G, Krawczak M, Heyckendorf J, Bahmer T.   +24 more
europepmc   +1 more source

Chronic fatigue and headache in post-COVID-19 syndrome: a radiological and clinical evaluation. [PDF]

Front Neurol
Almeida GG, Alkan S, Hoepner R, Euler A, Diem L, Wagner F.   +5 more
europepmc   +1 more source

COVID-19, post-acute COVID-19 syndrome (PACS, “long COVID”) and post-COVID-19 vaccination syndrome (PCVS, “post-COVIDvac-syndrome”): Similarities and differences [PDF]

Pathology Research and Practice, 2023
Worldwide there have been over 760 million confirmed coronavirus disease 2019 (COVID-19) cases, and over 13 billion COVID-19 vaccine doses have been administered as of April 2023, according to the World Health Organization. An infection with severe acute
Felix Scholkmann
exaly   +2 more sources

Post-COVID-19 Tachycardia Syndrome: A Distinct Phenotype of Post-Acute COVID-19 Syndrome

American Journal of Medicine, 2021
In this paper we highlight the presence of tachycardia in Post-acute Covid-19 Syndrome by introducing a new label for this phenomenon: Post-covid-19 tachycardia syndrome and argue that this constitutes a phenotype or sub-syndrome in PACS. We also discuss
Marcus Stahlberg, Ulrika Reistam, Artur Fedorowski   +2 more
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Post-COVID-19 asthenic syndrome

Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova, 2021
To study the features of asthenic syndrome and the possibilities of its therapy in patients in the post-covid period.The study included 129 patients with an average age of 49.8±8.9 years who had undergone COVID-19 using a continuous sample method. Patients for the study were selected at the clinical bases of outpatient clinics in Samara (Russia) in ...
I A, Zolotovskaia, P R, Shatskaia, I L, Davydkin, O A, Shavlovskaya   +3 more
openaire   +2 more sources

Post-COVID-19 Syndrome and the Potential Benefits of Exercise [PDF]

International Journal of Environmental Research and Public Health, 2021
The coronavirus disease (COVID-19), caused by severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) infection, is leading to unknown and unusual health conditions that are challenging to manage. Post-COVID-19 syndrome is one of those challenges, having become increasingly common as the pandemic evolves. The latest estimates suggest that 10 to 20%
Jesus G Pallares, Angel Buendía-Romero, Alejandro Martínez-Cava   +2 more
exaly   +4 more sources

Ophthalmological manifestations of post-COVID-19 syndrome

Vestnik oftal'mologii, 2021
The review presents data on damage to the organ of vision in patients recovered from the new coronavirus infection reflecting on the results obtained by various researchers from examining patients with varying severity of the disease, both during the active stage and after recovery.
Yu N, Yusef, E E, Kazaryan, D V, Andzhelova, M V, Vorobyova   +3 more
openaire   +2 more sources

Post-COVID-19 neurologic syndrome

JAAPA, 2022
ABSTRACT COVID-19 quickly escalated to a global pandemic in 2020. As research on the topic continues, the medical community has found that this acute illness can cause a new chronic illness: postacute sequelae of SARS-CoV-2 (PASC). Some patients with PASC develop predominately neurologic sequelae (post-COVID-19 neurologic syndrome or PCNS ...
Joshua D, Luciew, Rodney A, Erickson, Tara K, Kaufman   +2 more
openaire   +2 more sources

POST-COVID-19 INTERSTITIAL LUNG DISEASE AS A MANIFESTATION OF THE POST-COVID-19 SYNDROME

Ukrainian Pulmonology Journal, 2023
The aim was to study the clinical features of post-COVID-19 interstitial lung disease (ILD) and to determine the prospects for the use of the antifibrotic drug nintedanib in patients with moderate and severe COVID-19. Material and methods. A prospective cohort study was conducted in 266 patients (≥ 18 years old) with moderate and severe COVID-19 who ...
O. К. Yakovenkо, Y. O. Dziublyk, О. G. Khanin, L. Ya. Romaniv, L. M. Dzhumaniuk, E. M. Khodosh   +5 more
openaire   +1 more source

[Post-COVID-19 neuropsychological syndrome].

Revue medicale suisse, 2023
Recent observations suggest the persistence of neurological and neuropsychological symptoms in the long-term following SARS-CoV-2 infection. Currently described within the post-COVID-19 syndrome. The objective of this article is to discuss recent epidemiological data and data from neuroimaging studies. Finally, a discussion is proposed regarding recent
Philippe, Voruz, Isabele, Jacot De Alcântara, Alexandre, Cionca, Anthony, Nuber-Champier, Frédéric, Assal, Julie Anne, Peron   +5 more
openaire   +1 more source